Cardiac Resynchronization Therapy Market
Cardiac Resynchronization Therapy Market Analysis by Product Type (CRT-Defibrillator, RT-Pacemaker), by End-user Type, by Region - Global Forecast 2022 to 2032
Analysis of Cardiac Resynchronization Therapy market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cardiac Resynchronization Therapy Market Outlook
Newly-released Cardiac Resynchronization Therapy industry analysis report by Fact.MR shows that global sales of Cardiac Resynchronization Therapy in 2021 were held at US$ 5.7 Bn. With 7.9%, the projected market growth during 2022 to 2032 is expected to be slightly lower than the historical growth. CRT-Defibrillator is expected to be the higher revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 4 Bn during 2022 to 2032.
Revenue of Cardiac Resynchronization Therapy from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the Cardiac Resynchronization Therapy industry research by Fact.MR - market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Cardiac Resynchronization Therapy industry increased at around 8.0% CAGR, wherein, countries such as the U.S., China, Canada, India, and the UK held a significant share in the global market.
The increasing prevalence of diseases is driving the market's growth (primarily due to the rising geriatric population). Rising investments and support, as well as technology improvements, are all helping to drive this market forward.
- The Cardiac Resynchronization Therapy market reached a valuation of US$ 5.7 Bn in 2021 and it grew by 9.2% as compared to the previous year’s value which stood at US$ 5.2 Bn. Fact.MR estimates that cardiac resynchronization therapy revenue will grow from 2022 to 2032, reaching nearly US$ 13.2 Bn in 2032.
- The CRT-Defibrillator and CRT-Pacemaker product types segments of The Cardiac Resynchronization Therapy market reflected the market size of US$ 3.4Bn and US$ 2.3 Bn respectively in the year 2021
- From the end-user perspective, hospitals seized more than 50% market share in the year 2021.
- From the North America region, the United States is the leading country with a valuation of US$ 2.08 Bn in the year 2021
What are the Key Factors on the Basis of which Cardiac Resynchronization Therapy Market has been growing?
Device for cardiac resynchronization therapy that is CRT-D defibrillators combine the functions of an implanted cardioverter-defibrillator and a defibrillator to quickly resynchronize a dangerously fast cardiac rhythm. Cardiac resynchronization treatment is for patients with severe and moderate cardiac failure, pacemakers and defibrillators are becoming more significant therapeutic tools.
The devices for cardiac resynchronization therapy are implanted in the body. The pacemaker is small enough to fit in the palm of your hand and is inserted just below the collarbone. The device's leads monitor the heart rate to detect heart rate anomalies and send out tiny pulses to resynchronize the ventricles of the heart.
The therapeutic gadget helps to improve heart rhythm and the symptoms of arrhythmia. Owing to these factors cardiac resynchronization therapy market is projected to grow in leaps and bounds.
What Factors are pushing the Cardiac Resynchronization Therapy Market Ahead?
The growing cases of cardiovascular disease (CVD), the increasing number of surgical procedures performed, and the expanding number of critical care and intensive care units are some of the key factors driving the growth of the Cardiac Resynchronization Therapy market.
The global cardiac resynchronization therapy device market is being driven by awareness campaigns done by various healthcare sectors as well as government organizations for spreading knowledge related to the heart and ailments associated with it.
Cardiac resynchronization therapy is improving the clinical symptoms of patients with heart failure who have a ventricular conduction delay over time, making it a go-to option in today’s date with a positive trend.
What Factors are restraining the Cardiac Resynchronization Therapy Market?
The high cost of the cardiac resynchronization therapy device, as well as a lack of educated and skilled experts are limiting the growth of the cardiac resynchronization therapy market. Furthermore, the lack of data format interoperability is limiting the growth of cardiac resynchronization therapy.
Which Region is projected to offer the Largest Opportunity for Cardiac Resynchronization Therapy?
The market for cardiac resynchronization therapy in North America is growing at a steady pace. In 2021, North America had the highest revenue share of more than 40%. The growing geriatric population and regulatory clearances are responsible for the region's substantial proportion.
Research and innovation are being aided by increased access to large historical data in the sector. The American College of Cardiology (ACC) announced a suite of cardiovascular data registries in April 2021, allowing healthcare companies to assess and improve service quality using existing data.
The rising frequency of cardiovascular illnesses, the increased risk of obesity, rising disposable incomes, and the presence of multiple market competitors are some of the primary drivers of the regional market.
How Cardiac Resynchronization Therapy is improving heart failure management?
Although CRT is frequently considered only after the implementation of optimal medical heart failure therapy, it should be noted that only a small percentage of patients can tolerate maximal doses of neurohormonal blockers before CRT implantation. On the other hand, the acute and chronic haemodynamic effects of CRT may significantly alter the tolerability and acceptance of medical therapy.
CRT protects patients from AV conduction slowdown, bradycardia, and sinoatrial nodal pauses, allowing for safe beta-blocker titration. Furthermore, observational and randomized evidence implies that cardiac rehabilitation after CRT implant is linked to greater functional improvement and lower heart failure hospitalization and mortality.
How is Elderly Population Expected to Contribute Significantly to the Cardiac Resynchronization Therapy Market?
The Heart Rhythm Society produced guidelines for managing patients with cardiac implantable electronic devices in April 2020 COVID-19 task force update. This was done to put an emphasis on limiting exposure to patients and physicians. The elderly population is expected to be a key driver for market expansion. Statistics Korea estimates that 8.5 Mn people aged 65 and up will be alive in 2021.
By 2030, this figure is predicted to rise to 12.9 Mn. Chronic disorders such as congestive heart failure, hypertension, and arrhythmia are becoming more common as the population ages. This is expected to add to the market growth of the country. In a study published in the Archives of Cardiovascular Diseases in 2019, the European Society of Cardiology discovered that French patients are more likely than the rest of Europe to obtain a CRT-P implant.
What Techniques are Being Used to Combat the Underuse of Cardiac Resynchronization Therapy?
Improved ways to identify prospective eligible CRT candidates by cardiologists and non-cardiologists are urgently needed, as a referral is one of the barriers to installation. In addition, ECG surveillance in heart failure patients is recommended since anomalies not only provide information on the underlying cause but also aid in the selection of appropriate therapy.
Involvement with patient organizations or support groups on a more personal level could help to increase the spread of information about therapy choices. More actionable referrals could be triggered by screening through automated alerts in electronic health records based on information from QRS duration, left ventricular (LV) function, and heart failure state.
Screening for individuals eligible for optimization of heart failure therapy, including CRT, may be as effective as it has been for other heart failure treatments, with the proliferation of electronic health data.
Country-wise Analysis
Which Country represents the Strongest Revenue Potential in the Coming years for Cardiac Resynchronization Therapy Revenue?
According to the American Heart Association's Heart & Stroke Statistics report from 2020, about 356,000 cases of out-of-hospital cardiac arrest (OHCA) occur in the United States each year, with around 90% of these being fatal. In such cases, Cardiac resynchronization therapy (CRT) becomes a mode of solution.
Category-wise Insights
Why CRT-Defibrillator is Gaining the Utmost Traction when compared with CRT-Pacemaker?
In 2021, the CRT-defibrillators product segment was more profitable, accounting for more than 58% of global revenue. This is mostly due to the growing recognition of CRT-Ds as a viable alternative to pacemakers, as well as the introduction of technologically improved devices.
According to a study by National Cardiovascular Data Registry for implantable cardioverter-defibrillators, conducted on over 85,000 new CRT-D implants patients, there has been an increase in guideline-concordant implantation during the time in a study of through the.
How has COVID-19 Eventually Harmed the Revenue Generation from Cardiac Resynchronization Therapy?
The COVID-19 pandemic affected the market, resulting in lower demand and sales. This was due to cancelled elective treatments as a result of the pandemic, as well as delays in clinical trials, supply chain issues, and reduced sales and marketing activity.
MicroPort, one of the leading market players saw a 16.2% drop in its cardiac rhythm management business. The business blamed the drop on the COVID-19 epidemic, which caused outpatient appointments and surgical procedures to be postponed, resulting in fewer implants.
Competitive Analysis
During the projection period, market competition is expected to be moderate. Medtronic, Abbott, Boston Scientific Corporation, MicroPort BIOTRONIK, and Medico are all major competitors in the cardiac resynchronization therapy industry.
These businesses have a wealth of resources, market knowledge, a strong distribution network, and are engaged in strategic initiatives to expand market share and profitability. Mergers and acquisitions, regional expansion, collaborations, the launch of new goods, and R&D operations are all instances of these tactics.
Some of the recent developments of Cardiac Resynchronization Therapy providers are as follows :
- In January 2022, Medtronic has announced a $4 million initiative to increase diversity in STEM professions.
- In February 2020, Abbott introduced the latest gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices that have achieved CE Mark, offering the most modern heart rhythm management capabilities to patients.
- In March 2019, BIOTRONIK introduced the world's smallest 3T full-body MR conditional ICD and CRT-D devices in the European market.
Similarly, recent developments related to companies offering Cardiac Resynchronization Therapy have been tracked by the team at Fact.MR, which are available in the full report.
Cardiac Resynchronization Therapy Report Scope
| Report Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Russia, China, Japan, South Korea, India, Saudi Arabia, Australia, South Africa, The United Arab Emirates |
| Key Companies Profiled | Medtronic; Boston Scientific; Abbott Laboratories; Biotronik; MicroPort Scientific Corporation; Medico; Scranton Gillette |
Market Segments Covered in Cardiac Resynchronization Therapy Industry Analysis
-
By Product Type :
- CRT-Defibrillator
- CRT-Pacemaker
-
By End-user Type :
- Hospital
- Cardiac Center
- Other End-users
-
By region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Key Success Factors
- 6. Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 7. Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 8. Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
- 8.1. CRT-Defibrillator
- 8.2. CRT-Pacemaker
- 9. Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-User
- 9.1. Commercial
- 9.2. Cardiac Center
- 9.3. Other End-Users
- 10. Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Europe
- 10.4. APAC
- 10.5. Middle East and Africa (MEA)
- 11. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 12. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 13. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 14. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 16. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Medtronic
- 18.2. Boston Scientific
- 18.3. Abbott Laboratories
- 18.4. Biotronik
- 18.5. MicroPort Scientific Corporation
- 18.6. Medico
- 18.7. Scranton Gillette
- 19. Assumptions and Acronyms Used
- 20. Research Methodology
List Of Table
Table 1: Global Market Value (US$ Mn), By Product Type, 2015 to 2021
Table 2: Global Market Value (US$ Mn), By Product Type, 2022 to 2032
Table 3: Global Market Value (US$ Mn), By End-User, 2015 to 2021
Table 4: Global Market Value (US$ Mn), By End-User, 2022 to 2032
Table 5: Global Market, By Region, 2015 to 2021
Table 6: Global Market, By Region, 2022 to 2032
Table 7: North America Market Value (US$ Mn), By Product Type, 2015 to 2021
Table 8: North America Market Value (US$ Mn), By Product Type, 2022 to 2032
Table 9: North America Market Value (US$ Mn), By End-User, 2015 to 2021
Table 10: North America Market Value (US$ Mn), By End-User, 2022 to 2032
Table 11: North America Market, By Country, 2015 to 2021
Table 12: North America Market, By Country, 2022 to 2032
Table 13: Latin America Market Value (US$ Mn), By Product Type, 2015 to 2021
Table 14: Latin America Market Value (US$ Mn), By Product Type, 2022 to 2032
Table 15: Latin America Market Value (US$ Mn), By End-User, 2015 to 2021
Table 16: Latin America Market Value (US$ Mn), By End-User, 2022 to 2032
Table 17: Latin America Market, By Country, 2015 to 2021
Table 18: Latin America Market, By Country, 2022 to 2032
Table 19: Europe Market Value (US$ Mn), By Product Type, 2015 to 2021
Table 20: Europe Market Value (US$ Mn), By Product Type, 2022 to 2032
Table 21: Europe Market Value (US$ Mn), By End-User, 2015 to 2021
Table 22: Europe Market Value (US$ Mn), By End-User, 2022 to 2032
Table 23: Europe Market, By Country, 2015 to 2021
Table 24: Europe Market, By Country, 2022 to 2032
Table 25: Asia Pacific Market Value (US$ Mn), By Product Type, 2015 to 2021
Table 26: Asia Pacific Market Value (US$ Mn), By Product Type, 2022 to 2032
Table 27: Asia Pacific Market Value (US$ Mn), By End-User, 2015 to 2021
Table 28: Asia Pacific Market Value (US$ Mn), By End-User, 2022 to 2032
Table 29: Asia Pacific Market, By Country, 2015 to 2021
Table 30: Asia Pacific Market, By Country, 2022 to 2032
Table 31: MEA Market Value (US$ Mn), By Product Type, 2015 to 2021
Table 32: MEA Market Value (US$ Mn), By Product Type, 2022 to 2032
Table 33: MEA Market Value (US$ Mn), By End-User, 2015 to 2021
Table 34: MEA Market Value (US$ Mn), By End-User, 2022 to 2032
Table 35: MEA Market, By Country, 2015 to 2021
Table 36: MEA Market, By Country, 2022 to 2032
Table 37: Global Market Incremental $ Opportunity, By Product Type, 2015 to 2021
Table 38: Global Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 39: Global Market Incremental $ Opportunity, By Region, 2022 to 2032
Table 40: North America Market Incremental $ Opportunity, By Product Type, 2015 to 2021
Table 41: North America Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 42: North America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 43: Latin America Market Incremental $ Opportunity, By Product Type, 2015 to 2021
Table 44: Latin America Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 45: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 46: Europe Market Incremental $ Opportunity, By Product Type, 2015 to 2021
Table 47: Europe Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 48: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 49: Asia Pacific Market Incremental $ Opportunity, By Product Type, 2015 to 2021
Table 50: Asia Pacific Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 51: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032
Table 52: MEA Market Incremental $ Opportunity, By Product Type, 2015 to 2021
Table 53: MEA Market Incremental $ Opportunity, By End-User, 2022 to 2032
Table 54: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
List Of Figures
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 2: Global Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Mn
Figure 3: Global Market Share, By Product Type, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Product Type – 2022 to 2032
Figure 5: Global Market Attractiveness Index, By Product Type – 2022 to 2032
Figure 6: Global Market Share, By End-User, 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By End-User – 2022 to 2032
Figure 8: Global Market Attractiveness Index, By End-User – 2022 to 2032
Figure 9: Global Market Share, By Region, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Region – 2022 to 2032
Figure 11: Global Market Attractiveness Index, By Region – 2022 to 2032
Figure 12: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 13: North America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 14: North America Market Share, By Product Type, 2022 & 2032
Figure 15: North America Market Y-o-Y Growth Projections, By Product Type – 2022 to 2032
Figure 16: North America Market Attractiveness Index, By Product Type – 2022 to 2032
Figure 17: North America Market Share, By End-User, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Projections, By End-User – 2022 to 2032
Figure 19: North America Market Attractiveness Index, By End-User – 2022 to 2032
Figure 20: North America Market Share, By Country, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 22: North America Market Attractiveness Index, By Country – 2022 to 2032
Figure 23: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 24: Latin America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 25: Latin America Market Share, By Product Type, 2022 & 2032
Figure 26: Latin America Market Y-o-Y Growth Projections, By Product Type – 2022 to 2032
Figure 27: Latin America Market Attractiveness Index, By Product Type – 2022 to 2032
Figure 28: Latin America Market Share, By End-User, 2022 & 2032
Figure 29: Latin America Market Y-o-Y Growth Projections, By End-User – 2022 to 2032
Figure 30: Latin America Market Attractiveness Index, By End-User – 2022 to 2032
Figure 31: Latin America Market Share, By Country, 2022 & 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 33: Latin America Market Attractiveness Index, By Country – 2022 to 2032
Figure 34: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 35: Europe Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 36: Europe Market Share, By Product Type, 2022 & 2032
Figure 37: Europe Market Y-o-Y Growth Projections, By Product Type – 2022 to 2032
Figure 38: Europe Market Attractiveness Index, By Product Type – 2022 to 2032
Figure 39: Europe Market Share, By End-User, 2022 & 2032
Figure 40: Europe Market Y-o-Y Growth Projections, By End-User – 2022 to 2032
Figure 41: Europe Market Attractiveness Index, By End-User – 2022 to 2032
Figure 42: Europe Market Share, By Country, 2022 & 2032
Figure 43: Europe Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 44: Europe Market Attractiveness Index, By Country – 2022 to 2032
Figure 45: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 46: MEA Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 47: MEA Market Share, By Product Type, 2022 & 2032
Figure 48: MEA Market Y-o-Y Growth Projections, By Product Type – 2022 to 2032
Figure 49: MEA Market Attractiveness Index, By Product Type – 2022 to 2032
Figure 50: MEA Market Share, By End-User, 2022 & 2032
Figure 51: MEA Market Y-o-Y Growth Projections, By End-User – 2022 to 2032
Figure 52: MEA Market Attractiveness Index, By End-User – 2022 to 2032
Figure 53: MEA Market Share, By Country, 2022 & 2032
Figure 54: MEA Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 55: MEA Market Attractiveness Index, By Country – 2022 to 2032
Figure 56: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015 to 2032
Figure 57: Asia Pacific Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Mn
Figure 58: Asia Pacific Market Share, By Product Type, 2022 & 2032
Figure 59: Asia Pacific Market Y-o-Y Growth Projections, By Product Type – 2022 to 2032
Figure 60: Asia Pacific Market Attractiveness Index, By Product Type – 2022 to 2032
Figure 61: Asia Pacific Market Share, By End-User, 2022 & 2032
Figure 62: Asia Pacific Market Y-o-Y Growth Projections, By End-User – 2022 to 2032
Figure 63: Asia Pacific Market Attractiveness Index, By End-User – 2022 to 2032
Figure 64: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 65: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022 to 2032
Figure 66: Asia Pacific Market Attractiveness Index, By Country – 2022 to 2032
Figure 67: US Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 68: US Market Share, By Product Type, 2021
Figure 69: US Market Share, By End-User, 2021
Figure 70: Canada Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 71: Canada Market Share, By Product Type, 2021
Figure 72: Canada Market Share, By End-User, 2021
Figure 73: Brazil Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 74: Brazil Market Share, By Product Type, 2021
Figure 75: Brazil Market Share, By End-User, 2021
Figure 76: Mexico Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 77: Mexico Market Share, By Product Type, 2021
Figure 78: Mexico Market Share, By End-User, 2021
Figure 79: Germany Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 80: Germany Market Share, By Product Type, 2021
Figure 81: Germany Market Share, By End-User, 2021
Figure 82: U.K. Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 83: U.K. Market Share, By Product Type, 2021
Figure 84: U.K. Market Share, By End-User, 2021
Figure 85: France Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 86: France Market Share, By Product Type, 2021
Figure 87: France Market Share, By End-User, 2021
Figure 88: Italy Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 89: Italy Market Share, By Product Type, 2021
Figure 90: Italy Market Share, By End-User, 2021
Figure 91: BENELUX Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 92: BENELUX Market Share, By Product Type, 2021
Figure 93: BENELUX Market Share, By End-User, 2021
Figure 94: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 95: Nordic Countries Market Share, By Product Type, 2021
Figure 96: Nordic Countries Market Share, By End-User, 2021
Figure 97: China Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 98: China Market Share, By Product Type, 2021
Figure 99: China Market Share, By End-User, 2021
Figure 100: Japan Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 101: Japan Market Share, By Product Type, 2021
Figure 102: Japan Market Share, By End-User, 2021
Figure 103: South Korea Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 104: South Korea Market Share, By Product Type, 2021
Figure 105: South Korea Market Share, By End-User, 2021
Figure 106: GCC Countries Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 107: GCC Countries Market Share, By Product Type, 2021
Figure 108: GCC Countries Market Share, By End-User, 2021
Figure 109: South Africa Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 110: South Africa Market Share, By Product Type, 2021
Figure 111: South Africa Market Share, By End-User, 2021
Figure 112: Turkey Market Value (US$ Mn) and Forecast, 2022 to 2032
Figure 113: Turkey Market Share, By Product Type, 2021
Figure 114: Turkey Market Share, By End-User, 2021
- FAQs -
How much is the current worth of the Cardiac Resynchronization Therapy market?
The global Cardiac Resynchronization Therapy market is worth US$ 6.1 Bn at present.
What is the sales forecast for Cardiac Resynchronization Therapy?
Value of Cardiac Resynchronization Therapy is projected to increase at a CAGR of around 7.9% during 2022 – 2032.
What was the last 5 year’s market CAGR?
Value of Cardiac Resynchronization Therapy increased at a CAGR of around 8% during 2017 – 2021.
Which segment has a better grip over the market in terms of product type in the year 2021?
CRT-Defibrillator has better stats, accounting for more than 58% of global revenue when compared with CRT-Pacemaker in 2021
What is a key trend shaping the growth of the market for Cardiac Resynchronization Therapy?
The growing importance of CRT-D devices and a variety of additional devices which have become more common in recent years (as the frequency and mortality of cardiovascular diseases have increased-CVD) are some of the major key trends shaping the growth of
Which are the top 5 countries driving demand for Cardiac Resynchronization Therapy?
The top 5 countries driving the demand for Cardiac Resynchronization Therapy are the U.S., China, Canada, India, and the UK
What is the outlook for the market in North America?
North America accounted for over 40% of global Cardiac Resynchronization Therapy demand in 2021.
At what percentage is sales of Cardiac Resynchronization Therapy going to register growth in Europe?
The European market for Cardiac Resynchronization Therapy is projected to expand at a CAGR of around 8.2% during 2022 – 2032.
What do statistics for South Korea and Japan reveal?
While the market in South Korea is expected to grow at nearly 6.9%, the market in Japan is projected to register a CAGR of nearly 9.6% during 2022 - 2032.
Cardiac Resynchronization Therapy Market